HIV Status Tied to Greater Risk of Death Following Heart Attack, Large Examination of Hospital Records Finds
TheBodyPRO.com's independent coverage of ICAAC 2012 is not associated with the conference itself. Please note that all links on this page will take you to articles on TheBodyPRO.com, TheBody.com's sister site for health care professionals.
TheBodyPRO.com is an independent website not associated with this conference.
The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) is expected to draw approximately 10,000 attendees, most of them clinicians and researchers, from throughout the world to present and discuss the latest developments in infectious disease etiology, epidemiology and clinical management. Although it is not an HIV-specific conference, studies on HIV and related complications/coinfections often make up a significant proportion of the conference's presentations.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|